Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 51655-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 51655-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 075 52)

Label (51655 075 52)
Label for Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg, containing 30 tablets. The label indicates prescription use only with storage instructions and manufacturer details for Northwind Health Company, LLC. It includes batch, lot, and expiration placeholders and advises not to split, chew, or crush tablets.*
FDA Label Image

Chemical Structure (Pantoprazole Str)

Chemical Structure (Pantoprazole Str)
Chemical structure of pantoprazole sodium with components including a substituted benzimidazole and benzene ring, showing the sodium ion and 1.5 molecules of water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.